We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA announced late Friday that it has decided to expand its Emergency Use Authorization (EUA) for Gilead Sciences’ remdesivir, allowing its use in patients with mild or moderate COVID-19 infections. Read More
Vancouver, Wash.-based drugmaker CytoDyn is seeking an Emergency Use Authorization (EUA) from the FDA for its HIV treatment leronlimab for the treatment of mild-to-moderate COVID-19 patients. Read More